Sevoflurane Liquid
Product Images NDC 66794-022

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sevoflurane (NDC 66794-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing the concentration of Compound A in parts per million (ppm) plotted against Fresh Gas Flow Rate in liters per minute (L/min). The curve indicates a decrease in Compound A concentration as the fresh gas flow rate increases, with values ranging from about 24 ppm at 0.5 L/min to approximately 7 ppm at 4 L/min.*

FDA Label Image

Figure10 (Figure10)

A line graph showing the relationship between MAC level (x-axis) and a respiratory measurement in L/min/m2 (y-axis) for Sevoflurane administered with O2 and with O2/N2O. The graph compares two groups indicated by different symbols (diamonds and triangles) across MAC levels from baseline to 2.5, with error bars representing variability.*

FDA Label Image

Figure2 (Figure2)

A line graph showing the relationship between carbon dioxide flow in mL/min (x-axis) and compound A concentration in ppm along with maximum temperature in degrees Celsius (y-axis). Two lines are plotted: one for compound A concentration marked with circles, increasing with CO2 flow, and another for maximum temperature marked with squares, also increasing as CO2 flow rises.*

FDA Label Image

Figure2a (Figure2a)

A scatter plot with a fitted linear regression line showing the relationship between sevoflurane (MAC·Hour) on the x-axis and inspired compound A AUC (ppm·hr) on the y-axis. The plot includes the correlation coefficient (r = 0.096) and p-value (p < 0.001), indicating statistical analysis results for the data points.*

FDA Label Image

Figure3 (Figure3)

A line graph showing the relationship between the fraction of agent in alveolar gas to inspired concentration (FA/FI) over 30 minutes of administration for five anesthetic agents: Halothane, Isoflurane, Sevoflurane, Desflurane, and Nitrous Oxide (N2O). The graph compares uptake rates during respiratory inhalation.*

FDA Label Image

Figure4 (Figure4)

A line graph depicting the elimination rates of various inhalation anesthetics over time. The y-axis shows the ratio FA/FAO on a logarithmic scale, and the x-axis represents minutes of elimination from 0 to 120. The graph includes data lines for Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O, illustrating their comparative elimination profiles.*

FDA Label Image

Figure5 (Figure5)

A line graph depicting serum fluoride levels (in µM) over several days post-anesthesia with five inhalation anesthetics: Methoxyflurane, Sevoflurane, Enflurane, Isoflurane, and Halothane. The x-axis represents days post-anesthesia from pre-anesthesia to 6 days, and the y-axis shows serum fluoride concentration with error bars for variability. Each anesthetic is differentiated by symbols and sample size (n) noted in the legend.*

FDA Label Image

Figure6 (Figure6)

A line graph showing mean concentration of a substance over time in hours with curves for mean concentration plus one, two, and three standard deviations. The x-axis represents time in hours from 0 to 50, and the y-axis shows concentration in micromolar (µM) from 0 to 70.*

FDA Label Image

Figure7 (Figure7)

Line graph depicting heart rate in beats per minute across different MAC (minimum alveolar concentration) levels at baseline, 1, 1.5, and 2. The chart compares two groups labeled A (Sevo/O2) and C (Sevo/O2/N2O), with A represented by diamonds and C by triangles, including error bars for variability.*

FDA Label Image

Figure8 (Figure8)

A line chart showing mmHg measurements plotted against MAC level for two groups: Sevoflurane with O2 (diamonds) and Sevoflurane with O2 and N2O (triangles). Baseline values are shown. The graph depicts changes in mmHg values as MAC level increases from baseline through 2.5.*

FDA Label Image

Figure9 (Figure9)

A line chart depicting the relationship between MAC (Minimum Alveolar Concentration) level and airway resistance measured in dynes·sec·cm⁻⁵. Two data series are shown: Sevoflurane with oxygen (Sevo/O2) marked by diamonds, and Sevoflurane with oxygen and nitrous oxide (Sevo/O2/N2O) marked by triangles, with error bars indicating variability at each data point.*

FDA Label Image

Label (Label 250ml)

Label for Sevoflurane, USP 250 mL inhalation liquid anesthetic by Piramal Critical Care Inc. The label highlights the product name, concentration, and indicates it is for inhalation anesthesia. Storage instructions and manufacturing details are included, as well as the product NDC 66794-022-25.*

FDA Label Image

Sevo-structure (Sevo Structure)

Chemical structure of Sevoflurane, showing its molecular arrangement with trifluoromethyl groups and ether linkage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.